Marta Garrido Marin Institutions of which they are part Predoctoral researcher Ophtalmology Vall Hebron Institut de Recerca Email Marta Garrido Marin Email Institutions of which they are part Predoctoral researcher Ophtalmology Vall Hebron Institut de Recerca
Projects Clinical development of RetSit@, a first-in-class neuroprotective drug to treat Early Stages of Diabetic Retinopathy IP: Rafael Simó Canonge Collaborators: Olga Simó Servat, Marta Garrido Marin, Miguel Angel Zapata Victori Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 602031 Reference: CPP2023-010602 Duration: 01/10/2024 - 30/09/2027
